Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q2 2024 · 10-Q
Revenue$99.90M$99.90M+23.3% vs Q2 2023 Net Income-$34.69M-$34.69MN/M vs Q2 2023 EPS Diluted-$0.55-$0.55N/M vs Q2 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Operating Cash Flowderived$43,718,000+14.5% Free Cash Flowderived$43,718,000+14.5% Margins · derivedGross margin85.1%
Operating margin54.7%
Net margin-34.7%−36.3 pt vs Q2 2023
ended Jun 30, 2024 · filed Jul 31, 2024 · 31 d after period end